Project EXPLORER: clinical trials are currently underway

The first patients enrolled in the clinical trials have benefitted from non-invasive assessments using molecular imprinting, a new diagnostic tool. The Protool device captures key data concerning molecules, proteins, DNA, etc. from parts of the human body that were previously inaccessible.